Quintiles lands on Fortunes "Worlds Most Admired Companies" list

Quintiles (NYSE: Q) has landed on Fortune's list of the "World's Most Admired Companies." The Durham-based company is one of six North Carolina-headquartered firms to make the list.

Quintiles Named to CIO Top 100

Durham-based biopharmaceutical research company Quintiles has been named to the CIO 100 by CIO magazine, which identifies 100 companies that have created business value through information technology.

Durham's Quintiles Lands on Fortune 500

For the first time, Durham company Quintiles has appeared on the Fortune 500 at number 486 with more than $5 billion in revenue.

Durham's Quintiles Makes Computerworld's “100 Best Places to Work in IT" list

Durham-based Quintiles, a publicly traded biopharmaceutical services company that manages clinical trials for pharmaceutical companies, made it on the list of IDG’s Computerworld “100 Best Places to Work in IT list.”

Durham Company, Quintiles, Make Top 25 in Great Place to Work List

Durham-based Quintiles ranked No. 23 on the World’s Best Multinational Workplaces by the Great Place to Work Institute list.

Quintiles Ranked Fourth Among Technology Innovators

Durham-based pharmaceutical services company Quintiles ranked fourth in Information Week's annual rankings of the 500 top technology innovators.

Computerworld Names Quintiles a Best Place to Work in IT

Durham, NC-based biopharmaceutical services firm Quintiles ranks 52nd on Computerworld's list of Best Places to Work in IT.